PHARMA: UBS picks 2 pharma shares which can be probably to offer 23-26% returns
Brokerage UBS prefers Solar Pharma and Cipla amongst Indian drugmakers and expects the shares to return 26% and 23%, respectively,...
Pharma
Activists Problem Pharma Firm Gilead Over HIV Remedy — World Points
Activists protest through the twenty fifth Worldwide AIDS Convention (AIDS2024) in Munich over a reasonably priced pricing for a drug...
Block offers: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in Mankind Pharma
Canada Pension Plan Funding offloaded a partial stake in Nykaa via block offers on Wednesday. The international investor has offered...
mankind pharma block deal: Block Deal: Hema CIPEF prone to promote round 1% stake in Mankind Pharma
Mumbai: Hema CIPEF (I), an affiliate of the US-based Capital Group, is prone to promote a 0.9% stake in Mankind...
Indices: Inventory market replace: Nifty Pharma index falls 0.5%
NEW DELHI: The Nifty Pharma index closed on a destructive notice on Friday. Shares of Biocon Ltd.(up 1.26 per cent),...
